Galapagos NV Unveils New Employee Incentive Plans
Galapagos Creates New Subscription Right Plans
Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV ((Euronext &, NASDAQ:GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right
Galapagos NV Expands U.S. CAR-T Therapy Production
Galapagos Partners With Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture
Galapagos (GLPG.AS) said Wednesday that it is collaborating with Blood Centers of America to decentralize the manufacture of its CAR-T cell therapies. The Belgian pharmaceutical research company will
Galapagos and Blood Centers of America Announce Strategic Collaboration to Accelerate Galapagos' Decentralized CAR-T Manufacturing Network in the U.S.
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of
Express News | Galapagos NV : RBC Cuts Target Price to $35 From $38
Kepler Capital Sticks to Their Hold Rating for Galapagos (GLPG)
Earnings Call Summary | Galapagos(GLPG.US) Q1 2024 Earnings Conference
The following is a summary of the Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript:Financial Performance:Galapagos reported a net profit in Q1 2024 driven by adjustments in fair value, foreign exc
Galapagos First Quarter 2024 Earnings: EPS: €0.36 (Vs €0.35 in 1Q 2023)
Galapagos NV Reports Strong Q1 2024 Financials
Galapagos Reports Q1 Results
Galapagos Q1 EPS €1.40 Vs €0.40 YoY; Revenue €62.4 Million Vs €58.6 Million YoY
Results from our continuing operationsTotal operating loss from continuing operations for the three months ended 31 March 2024 was €33.1 million, compared to an operating loss of €14.2 million for the
Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT
Galapogos: Reconfirmed 2024 Cash Burn Guidance of EUR280M to EUR320M, Not Including Potential Business Development Opportunities >GLPG.BT
Galapogos 1Q EPS EUR1.40 >GLPG.BT
Galapogos 1Q EPS EUR1.40 >GLPG.BT
Galapagos NV Shareholders Approve Key Resolutions
Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV ((Euronext &, NASDAQ:GLPG) today announces that all resolutions proposed at the company's Annual and Extraordinary Shareholders' Meetings (AGM and EGM) held on
Express News | Morgan Stanley Maintains Equal-Weight on Galapagos, Maintains $38 Price Target
LG LAUNCHES VULNERABLE & ENDANGERED SPECIES AWARENESS CAMPAIGN IN TIMES SQUARE
3D anamorphic animal series kicks off LG's Earth Day activations; LG commits $150,000 in partnership with the National Wildlife Federation and Discovery EducationNEW YORK, April 16, 2024 /PRNewswire/
Galapagos NV Unveils CAR-T Therapy Advances
Galapagos Showcases Innovative Approach in Hematological Cancer Care With Clinical and Translational Data Presentations at EBMT Congress 2024
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen,